[Federal Register Volume 63, Number 123 (Friday, June 26, 1998)]
[Notices]
[Page 34901]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-17090]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Ethics Subcommittee and the Advisory Committee to the Director,
Centers for Disease Control and Prevention: Meetings
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following subcommittee and committee
meetings.
Name: Ethics Subcommittee of the Advisory Committee to the
Director, CDC.
Time and Date: 9 a.m.-3 p.m., July 16, 1998.
Place: CDC, Building 16, Room 5126, 1600 Clifton Road, NE,
Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 25 people.
Purpose: This subcommittee will anticipate, identify, and
propose solutions to strategic and broad ethical issues facing CDC.
Matters to be Discussed: Agenda items will include updates from
the Associate Director for Science, Dixie E. Snider, M.D., M.P.H., a
discussion on CDC's pandemic influenza plan, and ethical
consultation on blinded HIV serosurveys.
Name: Advisory Committee to the Director, CDC.
Time and Date: 8:30 a.m.-3 p.m., July 17, 1998.
Place: CDC, Auditorium A, 1600 Clifton Road, NE, Atlanta,
Georgia 30333.
Status: Open to the public, limited only by the space available.
Purpose: This committee advises the Director, CDC, on policy
issues and broad strategies that will enable CDC, the Nation's
prevention agency, to fulfill its mission of promoting health and
quality of life by preventing and controlling disease, injury, and
disability. The Committee recommends ways to incorporate prevention
activities more fully into health care. It also provides guidance to
help CDC work more effectively with its various constituents, in
both the private and public sectors, to make prevention a practical
reality.
Matters to be Discussed: Agenda items will include updates from
CDC Acting Director, Claire V. Broome, M.D., a report from the
Ethics Subcommittee, a discussion on counter terrorism and the
public health infrastructure, and the agency's prevention research
agenda.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Linda Kay McGowan,
Executive Secretary, Advisory Committee to the Director, CDC, 1600
Clifton Road, NE, M/S D-24, Atlanta, Georgia 30333, telephone 404/
639-7080.
Dated: June 22, 1998.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 98-17090 Filed 6-25-98; 8:45 am]
BILLING CODE 4163-18-P
